Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up
- 1 March 1992
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 57 (3) , 514-522
- https://doi.org/10.1016/s0015-0282(16)54893-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- THE EFFECTS OF NAFARELIN AND DANAZOL ON VERTEBRAL TRABECULAR BONE MASS IN PATIENTS WITH ENDOMETRIOSISClinical Endocrinology, 1990
- Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosisGynecological Endocrinology, 1990
- Comparison between the Effects of Nafarelin and Danazol on Serum Lipids and Lipoproteins in Patients with Endometriosis*Journal of Clinical Endocrinology & Metabolism, 1989
- Metabolic changes during medical treatment of endometriosis: Nafarelin acetate versus danazolAmerican Journal of Obstetrics and Gynecology, 1989
- Gonadotropin-Releasing Hormone (GnRH) Agonists in the Management of Endometriosis: A ReviewClinical Obstetrics and Gynecology, 1988
- The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone MetabolismJournal of Clinical Endocrinology & Metabolism, 1988
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Danazol treatment increases serum enzyme levelsFertility and Sterility, 1984
- DANAZOL AND LIVER DAMAGEThe Lancet, 1980